SGD Pharma, a global provider of molded glass primary packaging solutions for the pharmaceutical industry, opened a new siliconization operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant. The company enhances its range of in-house services by internalizing its glass siliconization offering for the supply and improved flexibility of vial sizes.       Glass vials are regularly used for pharmaceutical packaging, though there is a growing market need for primary packaging that is...